Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
NHS Warns Staff of Prosecution for Snooping Into Patient Data
Regulatory & Compliance NHS Warns Staff of Prosecution for Snooping Into Patient Data

The sanctity of medical privacy has reached a critical tipping point as healthcare administrators across the United Kingdom issue stern warnings regarding the severe legal consequences awaiting any employee who accesses patient files without a legitimate clinical justification. In an era where

How Did Done Global Run a Massive Adderall Fraud Scheme?
Regulatory & Compliance How Did Done Global Run a Massive Adderall Fraud Scheme?

The recent sentencing of Ruthia He and David Brody has sent shockwaves through the healthcare technology sector, effectively ending a dark chapter defined by the reckless commodification of controlled substances. Done Global operated not as a patient-centered medical provider but as a sophisticated

Done Global Executives Sentenced for Illegal Stimulant Sales
Digital Health Done Global Executives Sentenced for Illegal Stimulant Sales

The rapid expansion of telehealth services once promised a frictionless future for mental health care, yet the recent sentencing of high-level executives from Done Global serves as a stark reminder of the legal and ethical boundaries that must govern digital medicine. When federal investigators

Trend Analysis: Congressional Healthcare Oversight
Regulatory & Compliance Trend Analysis: Congressional Healthcare Oversight

The long-standing period of quiet diplomacy between the medical establishment and Capitol Hill is rapidly dissolving as the 120th Congress prepares to turn its focus toward aggressive, public-facing investigations. This shift signals the definitive end of a relatively passive regulatory era,

Can Non-Invasive Tests End the Endometriosis Diagnosis Wait?
Imaging & Diagnostics Can Non-Invasive Tests End the Endometriosis Diagnosis Wait?

For decades, the standard medical protocol for identifying endometriosis has required patients to undergo invasive laparoscopic surgery just to confirm a condition that affects nearly ten percent of the global female population during their reproductive years. This diagnostic bottleneck has

Medtronic Breach Reveals Growing Medtech Cybersecurity Risks
Regulatory & Compliance Medtronic Breach Reveals Growing Medtech Cybersecurity Risks

The convergence of digital infrastructure and critical patient care has transformed the modern medical technology landscape into a high-stakes environment where data security is now as vital as the clinical efficacy of the devices themselves. Following the discovery of unauthorized access to its

APA Launches Digital Badge Program for Mental Health Apps
Regulatory & Compliance APA Launches Digital Badge Program for Mental Health Apps

Navigating the sprawling landscape of over twenty thousand mental health applications currently available on major digital storefronts has become an overwhelming challenge for both patients seeking relief and clinicians aiming to provide evidence-based recommendations. For years, the absence of a

Can the $60 Rogbid Loop Air Challenge Premium Wearables?
Digital Health Can the $60 Rogbid Loop Air Challenge Premium Wearables?

The global smartwatch market is currently undergoing a radical shift as affordable devices bridge the gap between budget trackers and luxury high-performance models. Historically, consumers had to choose between bare-bones fitness bands or expensive flagship devices that often exceeded several

Is the 2026 Drug Strategy Building a Surveillance State?
Regulatory & Compliance Is the 2026 Drug Strategy Building a Surveillance State?

The transition of the 2026 National Drug Control Strategy from a medical intervention program into a high-tech surveillance architecture represents a seismic shift in how the federal government monitors the daily lives of American citizens. This 195-page blueprint, ostensibly designed to combat the

AI-Powered Specialty Pharmacy – Review
Digital Health AI-Powered Specialty Pharmacy – Review

The shift from traditional pharmacy fulfillment to hyper-personalized, data-driven health management is no longer a distant goal but a current reality redefining how chronic conditions are treated. Specialty pharmacies navigate a landscape where medication costs are soaring and patient needs are

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later